(Q28299100)
Statements
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer (English)
0 references
Ian P M Tomlinson
Rachel Midgley
Rajarajan Ramamoorthy
Yoko Yanagisawa
1 December 2013
0 references
Identifiers
2 references
2 references